Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

RATIONALE & OBJECTIVE: The benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation (AF) in patients with chronic kidney disease is uncertain. We compared rivaroxaban with warfarin across the range of kidney function in adults with AF. STUDY DESIGN: Multicenter retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Jeffrey T., Scaria, Anish, Andrade, Jason, Badve, Sunil V., Birks, Peter, Bota, Sarah E., Campain, Anna, Djurdjev, Ognjenka, Garg, Amit X., Harel, Ziv, Hemmelgarn, Brenda, Hockham, Carinna, James, Matthew T., Jardine, Meg J., Lam, Dickson, Levin, Adeera, McArthur, Eric, Ravani, Pietro, Shao, Selena, Sood, Manish M., Tan, Zhi, Tangri, Navdeep, Whitlock, Reid, Gallagher, Martin, Jun, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363562/
https://www.ncbi.nlm.nih.gov/pubmed/37492112
http://dx.doi.org/10.1016/j.xkme.2023.100675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363562/
https://www.ncbi.nlm.nih.gov/pubmed/37492112
http://dx.doi.org/10.1016/j.xkme.2023.100675

Ejemplares similares